EPH receptor A10 ; Homo sapiens






10 Article(s)
Download
PMID
Title
Journal
Pub. Date
#Total Relationship(s)
1 16516143 Potential clinical relevance of Eph receptors and ephrin ligands expressed in prostate carcinoma cell lines. Biochem Biophys Res Commun 2006 Apr 21 1
2 24403271 Expression of Eph receptor A10 is correlated with lymph node metastasis and stage progression in breast cancer patients. Cancer Med 2013 Dec 1
3 27574425 Anti-EphA10 antibody-conjugated pH-sensitive liposomes for specific intracellular delivery of siRNA. Int J Nanomedicine 2016 3
4 29513049 Eph A10-modified pH-sensitive liposomes loaded with novel triphenylphosphine-docetaxel conjugate possess hierarchical targetability and sufficient antitumor effect both in vitro and in vivo. Drug Deliv 2018 Nov 2
5 29798663 Overcoming Multidrug Resistance by Codelivery of MDR1-Targeting siRNA and Doxorubicin Using EphA10-Mediated pH-Sensitive Lipoplexes: In Vitro and In Vivo Evaluation. ACS Appl Mater Interfaces 2018 Jun 27 4
6 31815765 Anti-diabetic drug metformin inhibits cell proliferation and tumor growth in gallbladder cancer via G0/G1 cell cycle arrest. Anticancer Drugs 2020 Mar 1
7 32053275 Cataloguing the dead: breathing new life into pseudokinase research. FEBS J 2020 Oct 1
8 33436772 Ephrin A4-ephrin receptor A10 signaling promotes cell migration and spheroid formation by upregulating NANOG expression in oral squamous cell carcinoma cells. Sci Rep 2021 Jan 12 1
9 34431498 The intracellular domains of the EphB6 and EphA10 receptor tyrosine pseudokinases function as dynamic signalling hubs. Biochem J 2021 Sep 17 2
10 34949656 Artesunate-induced Cellular Effects Are Mediated by Specific EPH Receptors and Ephrin Ligands in Breast Carcinoma Cells. Cancer Genomics Proteomics 2022 Jan-Feb 3